These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 27528400)

  • 21. Molecular and immunohistochemical identification of p53 alterations in bone and soft tissue sarcomas.
    Mousses S; McAuley L; Bell RS; Kandel R; Andrulis IL
    Mod Pathol; 1996 Jan; 9(1):1-6. PubMed ID: 8821948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.
    Théoleyre S; Mori K; Cherrier B; Passuti N; Gouin F; Rédini F; Heymann D
    BMC Cancer; 2005 Sep; 5():123. PubMed ID: 16188028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma.
    Tomoda R; Seto M; Hioki Y; Sonoda J; Matsumine A; Kusuzaki K; Uchida A
    Clin Exp Metastasis; 2005; 22(7):559-64. PubMed ID: 16475026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RANKL blockade prevents and treats aggressive osteosarcomas.
    Chen Y; Di Grappa MA; Molyneux SD; McKee TD; Waterhouse P; Penninger JM; Khokha R
    Sci Transl Med; 2015 Dec; 7(317):317ra197. PubMed ID: 26659571
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesenchymal stem cells promote tumor engraftment and metastatic colonization in rat osteosarcoma model.
    Tsukamoto S; Honoki K; Fujii H; Tohma Y; Kido A; Mori T; Tsujiuchi T; Tanaka Y
    Int J Oncol; 2012 Jan; 40(1):163-9. PubMed ID: 21971610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
    Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
    JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.
    Benjamin R; Helman L; Meyers P; Reaman G
    Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2.
    Mohseny AB; Szuhai K; Romeo S; Buddingh EP; Briaire-de Bruijn I; de Jong D; van Pel M; Cleton-Jansen AM; Hogendoorn PC
    J Pathol; 2009 Nov; 219(3):294-305. PubMed ID: 19718709
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
    Mangerel J; Price A; Castelo-Branco P; Brzezinski J; Buczkowicz P; Rakopoulos P; Merino D; Baskin B; Wasserman J; Mistry M; Barszczyk M; Picard D; Mack S; Remke M; Starkman H; Elizabeth C; Zhang C; Alon N; Lees J; Andrulis IL; Wunder JS; Jabado N; Johnston DL; Rutka JT; Dirks PB; Bouffet E; Taylor MD; Huang A; Malkin D; Hawkins C; Tabori U
    Acta Neuropathol; 2014 Dec; 128(6):853-62. PubMed ID: 25315281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
    Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
    Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort.
    Ottaviano L; Schaefer KL; Gajewski M; Huckenbeck W; Baldus S; Rogel U; Mackintosh C; de Alava E; Myklebost O; Kresse SH; Meza-Zepeda LA; Serra M; Cleton-Jansen AM; Hogendoorn PC; Buerger H; Aigner T; Gabbert HE; Poremba C
    Genes Chromosomes Cancer; 2010 Jan; 49(1):40-51. PubMed ID: 19787792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary versus radiation-associated craniofacial osteosarcoma: Biologic and clinicopathologic comparisons.
    McHugh JB; Thomas DG; Herman JM; Ray ME; Baker LH; Adsay NV; Rabah R; Lucas DR
    Cancer; 2006 Aug; 107(3):554-62. PubMed ID: 16795069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival rates of homozygotic
    Strzemecki D; Guzowska M; Grieb P
    Cell Mol Biol Lett; 2017; 22():9. PubMed ID: 28536640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A guardian turned rogue: TP53 promoter translocations rewire stress responses to oncogenic effectors in osteosarcoma.
    Herold N
    Cancer Gene Ther; 2024 Jun; 31(6):805-806. PubMed ID: 38409586
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a children's oncology group study.
    Wasserman JD; Novokmet A; Eichler-Jonsson C; Ribeiro RC; Rodriguez-Galindo C; Zambetti GP; Malkin D
    J Clin Oncol; 2015 Feb; 33(6):602-9. PubMed ID: 25584008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TP53 intron 1 hotspot rearrangements are specific to sporadic osteosarcoma and can cause Li-Fraumeni syndrome.
    Ribi S; Baumhoer D; Lee K; Edison ; Teo AS; Madan B; Zhang K; Kohlmann WK; Yao F; Lee WH; Hoi Q; Cai S; Woo XY; Tan P; Jundt G; Smida J; Nathrath M; Sung WK; Schiffman JD; Virshup DM; Hillmer AM
    Oncotarget; 2015 Apr; 6(10):7727-40. PubMed ID: 25762628
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation spectrum of p53 gene in highly malignant human osteosarcomas.
    Radig K; Schneider-Stock R; Oda Y; Neumann W; Mittler U; Roessner A
    Gen Diagn Pathol; 1996 Jun; 142(1):25-32. PubMed ID: 8793483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteosarcomas With Few Chromosomal Alterations or Adult Onset Are Genetically Heterogeneous.
    Difilippo V; Saba KH; Styring E; Magnusson L; Nilsson J; Nathrath M; Baumhoer D; Nord KH
    Lab Invest; 2024 Jan; 104(1):100283. PubMed ID: 37931683
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene expression profiling of isogenic cells with different TP53 gene dosage reveals numerous genes that are affected by TP53 dosage and identifies CSPG2 as a direct target of p53.
    Yoon H; Liyanarachchi S; Wright FA; Davuluri R; Lockman JC; de la Chapelle A; Pellegata NS
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15632-7. PubMed ID: 12438652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creation and preliminary characterization of a Tp53 knockout rat.
    McCoy A; Besch-Williford CL; Franklin CL; Weinstein EJ; Cui X
    Dis Model Mech; 2013 Jan; 6(1):269-78. PubMed ID: 22917926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.